Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe record history now shows the latest revision as v3.6.3. This reflects a minor update to the study record's release notes in the revision history.SummaryDifference0.1%

- Check14 days agoChange DetectedA new page revision label v3.6.2 was added to the study record history, replacing the earlier v3.6.0 and signaling an update to the record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe history now includes a note that recruitment is closed (no longer looking for participants), and the current revision is marked as v3.6.0, with the prior v3.5.5 revision removed.SummaryDifference0.5%

- Check35 days agoChange DetectedThe study record history now includes a new revision entry, Revision: v3.5.5, replacing Revision: v3.5.4. This change updates the page’s version history but does not modify trial details or user-facing content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe Record History page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small site release updating the page's version label.SummaryDifference0.1%

- Check71 days agoChange DetectedThe record history now shows a new latest revision, v3.5.3, replacing the previous v3.5.2. This marks a minor platform update to the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.